Replies to post #6887 on Sesen Bio Inc (SESN)

[Bill_ENG]

They finished selling off their IL-6 antagonist and announced they are not wasting time and money on a new trial with the FDA in the US.

What they are doing is preserving assets for the sale of the company .

They will take the employee count to a skeleton crew, only those needed to inventory and process the sales contract .

That is why they took the reverse off the table, no need to further dilute and raise money.

Jmo

[MD3]

Not with Tommy boy at the helms. He knows exactly what to say to string investors along just before the rug pull